BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7829268)

  • 1. Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.
    Wolf J; Draube A; Bohlen H; Jox A; Mücke S; Pawlita M; Möller P; Diehl V
    Int J Cancer; 1995 Feb; 60(4):527-33. PubMed ID: 7829268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
    Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
    Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
    Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
    Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells.
    Tosato G; Sgadari C; Taga K; Jones KD; Pike SE; Rosenberg A; Sechler JM; Magrath IT; Love LA; Bhatia K
    Blood; 1994 Feb; 83(3):776-84. PubMed ID: 8298139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the tumorigenic growth of Burkitt's lymphoma cells in immunodeficient mice by cytokine gene transfer using EBV-derived episomal expression vectors.
    Mücke S; Draube A; Polack A; Pawlita M; Massoudi N; Staratschek-Jox A; Bohlen H; Bornkamm G; Diehl V; Wolf J
    Int J Cancer; 2000 May; 86(3):301-6. PubMed ID: 10760815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells.
    Gauchat JF; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Apr; 148(7):2291-9. PubMed ID: 1347554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude mice.
    Gurtsevitch VE; O'Conor GT; Lenoir GM
    Int J Cancer; 1988 Jan; 41(1):87-95. PubMed ID: 2826348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice.
    McCormick KH; Giovanella BC; Klein G; Nilsson K; Stehlin JS
    Int J Cancer; 1981 Oct; 28(4):455-8. PubMed ID: 6273332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma.
    Ogden CA; Pound JD; Batth BK; Owens S; Johannessen I; Wood K; Gregory CD
    J Immunol; 2005 Mar; 174(5):3015-23. PubMed ID: 15728515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Invasive, metastatic growth of lymphoblastoid B cells in immunodeficient SCID mice].
    Walter J; Wolf J; Pawlita M; Schirrmacher V; Moldenhauer G; Möller P
    Verh Dtsch Ges Pathol; 1991; 75():224-8. PubMed ID: 1724838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human B-lymphoid cell lines.
    Nilsson K
    Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.
    Miyauchi K; Urano E; Yoshiyama H; Komano J
    Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
    Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
    Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
    Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
    Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of interleukin 10 in B lymphocytes of different origin.
    Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
    Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: promotion of IL6 receptor expression by EBV.
    Klein SC; Jücker M; Abts H; Tesch H
    Hematol Oncol; 1995; 13(3):121-30. PubMed ID: 7622142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.